Death, time, and the theory of relativity: A brief reply?

Journal of Pain and Symptom Management

Volumn 43, Issue 3, 2012, Pages e2-

  Round, Jeff ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEATH; ECONOMIC ASPECT; FOOD; HEALTH; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH STATUS; HUMAN; LETTER; LIFE; QUALITY ADJUSTED LIFE YEAR; SOCIAL ASPECT; THEORY; TIME; UNITED KINGDOM;

EID: 84856914999     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.12.177     Document Type: Letter

References (20)

1. M.C. Weinstein A QALY is a QALY - or is it? J Health Econ 7 1988 289 290
2. National Institute for Health and Clinical Excellence (NICE) Appraising life-extending, end of life treatments 2009 NICE London, UK
3. M. Garau, K.K. Shah, and A.R. Mason Using QALYs in cancer: a review of the methodological limitations Pharmacoeconomics 29 2011 673 685
4. C. Normand Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs J Pain Symptom Manage 38 2009 27 31
5. H.M. Chochinov Death, time and the theory of relativity J Pain Symptom Manage 42 2011 460 463
6. M.E. Suarez-Almazor, B. Conner-Spady, C.J. Kendall, A.S. Russell, and K. Skeith Lack of congruence in the ratings of patients' health status by patients and their physicians Med Decis Making 21 2001 113 121 (Pubitemid 32318762)
7. M.E. Suarez-Almazor, and B. Conner-Spady Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses J Rheumatol 28 2001 648 656 (Pubitemid 32202678)
8. National Institute for Health and Clinical Excellence (NICE) Guide to the methods of technology appraisal 2008 NICE London, UK
9. P. Dolan Whose preferences count? Med Decis Making 19 1999 482 486 (Pubitemid 29474774)
10. M. Gold Panel on cost-effectiveness in health and medicine Med Care 34 12 Suppl 1996 DS197 DS199
11. A. Wailoo, A. Tsuchiya, and C. McCabe Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected Pharmacoeconomics 27 2009 983 989
12. J.M. Miyamoto, and S.A. Eraker A multiplicative model of the utility of survival duration and health quality J Exp Psychol Gen 117 1988 3 20
13. R. Edlin, J. Round, and C. McCabe Cost-effectiveness analysis and ageism: A review of the theoretical literature. [Prepared for the Department of Health.] 2008 Leeds Institute of Health Sciences Leeds, UK
14. Edlin R, Tsuchiya A, Dolan P. Measuring the societal value of lifetime health. Sheffield, UK: University of Sheffield, 2009. Available from http://eprints.whiterose.ac.uk/10006/1/SERPS2009010.pdf. Accessed December 1, 2011.
15. National Institute for Health and Clinical Excellence (NICE) Social value judgements: Principles for the development of NICE guidance 2008 NICE London, UK
16. P. Dolan, R. Edlin, and A. Tsuchiya The relative societal value of health gains to different beneficiaries 2011 NICE London, UK
17. J. Harris What is the good of health care? Bioethics 10 1996 269 291
18. J. Harris Does justice require that we be ageist? Bioethics 8 1994 74 83
19. M. Paulden, and A.J. Culyer Does cost-effectiveness analysis discriminate against patients with short life expectancy? Matters of logic and matters of context 2010 Centre for Health Economics, University of York York, UK
20. S. Morris, N. Devlin, and D. Parkin Economic analysis in health care 1st ed. 2007 John Wiley and Sons, Ltd Chichester, UK